mdl 72527 has been researched along with Inflammation in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Alfarhan, M; Baker, L; Henry-Ojo, HO; Liao, Y; Liu, F; Narayanan, SP; Shenoy, N; Somanath, PR | 1 |
Caldwell, RB; Caldwell, RW; Lucas, R; Narayanan, SP; Patel, C; Shosha, E; Xing, J; Xu, Z | 1 |
Casero, RA; Destefano Shields, CE; Goodwin, AC; Hacker-Prietz, A; Huso, DL; Murray-Stewart, TR; Rabizadeh, S; Sears, CL; Woster, PM; Wu, S; Wu, X | 1 |
3 other study(ies) available for mdl 72527 and Inflammation
Article | Year |
---|---|
Treatment with MDL 72527 Ameliorated Clinical Symptoms, Retinal Ganglion Cell Loss, Optic Nerve Inflammation, and Improved Visual Acuity in an Experimental Model of Multiple Sclerosis.
Topics: Animals; Encephalomyelitis, Autoimmune, Experimental; Inflammation; Mice; Models, Theoretical; Multiple Sclerosis; Optic Nerve; Optic Neuritis; Retinal Ganglion Cells; Visual Acuity | 2022 |
Treatment with polyamine oxidase inhibitor reduces microglial activation and limits vascular injury in ischemic retinopathy.
Topics: Animals; Cell Death; Cell Differentiation; Cells, Cultured; Culture Media, Conditioned; Disease Models, Animal; Enzyme Inhibitors; Female; Inflammation; Ischemia; Male; Mice; Mice, Inbred C57BL; Microglia; Oxidoreductases Acting on CH-NH Group Donors; Polyamine Oxidase; Putrescine; Rats; Retinal Diseases; Retinal Vessels | 2016 |
Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis.
Topics: Acetyltransferases; Animals; Bacterial Toxins; Bacteroides fragilis; Cell Line; Cell Proliferation; Colitis; Colonic Neoplasms; Disease Models, Animal; DNA Damage; Enzyme Induction; Epithelial Cells; Humans; Inflammation; Intestines; Mice; Mice, Inbred C57BL; Oxidoreductases Acting on CH-NH Group Donors; Polyamine Oxidase; Polyamines; Precancerous Conditions; Putrescine; Recombinant Proteins | 2011 |